Arrowhead Pharmaceuticals Inc is a pioneering biopharmaceutical company focused on developing innovative medicines for challenging diseases. With a robust pipeline, it targets conditions like hypertriglyceridemia, non-alcoholic steatohepatitis, and various pulmonary diseases, among others. Arrowhead is actively conducting clinical trials across different phases to combat diseases such as chronic hepatitis B, liver diseases, and alpha-1 antitrypsin deficiency-related liver disease. The company collaborates with industry giants like Janssen Pharmaceuticals and Amgen, showcasing its commitment to advancing healthcare. Founded in 2003 and based in Pasadena, California, Arrowhead is at the forefront of medical research.